Published in Ann Coloproctol on June 30, 2016
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol (2008) 15.17
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Lymphangiogenesis and cancer metastasis. Nat Rev Cancer (2002) 3.90
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28
Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol (2005) 2.38
Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg (1997) 2.23
Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. Br J Surg (1997) 2.18
Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg (2008) 2.09
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg (2010) 1.98
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2005) 1.92
Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum (2010) 1.79
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg (2008) 1.76
Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol (2009) 1.70
The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today (2011) 1.49
Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg (2010) 1.37
Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol (2011) 1.20
Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg (2008) 1.18
Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg (2008) 1.18
Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg (1998) 1.17
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2012) 1.16
Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc (2011) 1.04
Extended resections of liver metastases from colorectal cancer. World J Surg (2007) 1.00
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99
Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol (1988) 0.95
Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. J Hepatobiliary Pancreat Surg (1999) 0.93
Inclusion of vasculature-related variables in the Dukes staging system of colon cancer. Clin Cancer Res (2005) 0.90
Prognostic indicator for the resection of liver metastasis of colorectal cancer. Surg Today (2013) 0.89
Different incidence of synchronous liver metastasis between proximal and distal colon cancer. Surg Today (2011) 0.86
Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery (2008) 0.85
Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases. J Surg Oncol (2014) 0.81
Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery (2013) 0.79
Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience. HPB Surg (2013) 0.79
Synchronous colorectal liver metastasis in patients without node metastasis: possibility of localized liver metastasis. Hepatogastroenterology (2013) 0.76
Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys (2015) 0.94
Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report. Radiat Oncol J (2013) 0.94
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer. Cancer Res Treat (2014) 0.87
Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer. Radiat Oncol J (2014) 0.85
Assessment by Using a Water-Soluble Contrast Enema Study of Radiologic Leakage in Lower Rectal Cancer Patients With Sphincter-Saving Surgery. Ann Coloproctol (2015) 0.83
Comparison of abdominal and perineal procedures for complete rectal prolapse: an analysis of 104 patients. Ann Surg Treat Res (2014) 0.83
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. Clin Mol Hepatol (2015) 0.81
Changes in the types of liver diseases requiring hepatic resection: a single-institution experience of 9016 cases over a 10-year period. Korean J Hepatobiliary Pancreat Surg (2016) 0.81
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-containing Regimen. Cancer Res Treat (2016) 0.79
Prognosis of patients with pT1b/T2 gallbladder carcinoma who have undergone laparoscopic cholecystectomy as an initial operation. Korean J Hepatobiliary Pancreat Surg (2013) 0.78
Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2015) 0.78
Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome. Korean J Intern Med (2016) 0.78
Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma. Cancer Res Treat (2014) 0.77
Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection. Korean J Hepatobiliary Pancreat Surg (2012) 0.77
Effects of total body irradiation-based conditioning on allogeneic stem cell transplantation for pediatric acute leukemia: a single-institution study. Radiat Oncol J (2014) 0.77
Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma. J Med Imaging Radiat Oncol (2015) 0.77
Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct. Korean J Hepatobiliary Pancreat Surg (2012) 0.77
Pneumatosis intestinalis after adult living donor liver transplantation: report of three cases and collective literature review. Korean J Hepatobiliary Pancreat Surg (2015) 0.77
Survival analysis following resection of AJCC stage III gallbladder carcinoma based on different combinations of T and N stages. Korean J Hepatobiliary Pancreat Surg (2015) 0.76
Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. ANZ J Surg (2016) 0.76
Case report of a pancreatic squamoid cyst. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer. Cancer Res Treat (2016) 0.75
Effectiveness of external drainage of the bile duct in pancreaticoduodenectomy: a single surgeon's experience. Korean J Hepatobiliary Pancreat Surg (2011) 0.75
Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer. Radiat Oncol J (2016) 0.75
Preliminary Suggestion about Staging of Anorectal Malignant Melanoma May Be Used to Predict Prognosis. Cancer Res Treat (2015) 0.75
Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
In vitro immune cell monitoring as a guide for long-term immunosuppression in adult liver transplant recipients. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Reply to commentary on "clinical characteristics and adequate treatment of familial adenomatous polyposis combined with desmoid tumors". Cancer Res Treat (2015) 0.75
Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy. Korean J Intern Med (2016) 0.75
Calculation of standard liver volume in Korean adults with analysis of confounding variables. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Clinical significance of serum carcinoembryonic antigen level in rectal cancer patients who underwent preoperative chemoradiotherapy. J Korean Soc Coloproctol (2012) 0.75
Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus. Radiat Oncol J (2017) 0.75
Prognostic and Oncologic Significance of Perineural Invasion in Sporadic Colorectal Cancer. Ann Surg Oncol (2017) 0.75
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma. Oncotarget (2017) 0.75
Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer. Radiat Oncol J (2017) 0.75
Comparison of acute kidney injury between open and laparoscopic liver resection: Propensity score analysis. PLoS One (2017) 0.75
[Surgical Removal of Migrated Coil after Embolization of Jejunal Variceal Bleeding: A Case Report]. Korean J Gastroenterol (2017) 0.75
Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys (2016) 0.75
Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis. Int J Radiat Oncol Biol Phys (2017) 0.75
Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2. Radiat Oncol J (2017) 0.75